| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
|
| | Trecadrine Basic information |
| Product Name: | Trecadrine | | Synonyms: | (1R,2S)-alpha-(1-((2-(10,11-Dihydro-5H-dibenzo(A,D)cyclohepten-5-ylidene)ethyl)methylamino)ethyl)benzyl alcohol;Trecadrina;Trecadrina [spanish];Trecadrinum;Trecadrinum [latin];Unii-34H206R8A5;2-((2-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)ethyl)(methyl)amino)-1-phenylpropan-1-ol;Trecadrine | | CAS: | 90845-56-0 | | MF: | C27H29NO | | MW: | 383.53 | | EINECS: | | | Product Categories: | | | Mol File: | 90845-56-0.mol |  |
| | Trecadrine Chemical Properties |
| Boiling point | 552.986±38.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.150±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 13.864±0.20(predicted) |
| | Trecadrine Usage And Synthesis |
| Uses | Trecadrine is a β3-adrenergic agonist. | | in vivo | After 35 days of Trecadrine administration to the basal group in rats, galactose uptake by the intestinal tissue decreases significantly (by 19%, P<0.05)[1]. | | References | [1] Diez-Sampedro A, et al. Effects of trecadrine, a beta 3-adrenergic agonist, on intestinal absorption of D-galactose and disaccharidase activities in three physiopathological models. J Pharm Pharmacol. 1997 Sep;49(9):873-7. DOI:10.1111/j.2042-7158.1997.tb06128.x |
| | Trecadrine Preparation Products And Raw materials |
|